コンテンツへスキップ
Merck

1.37171

TWEEN® 80

high purity, EMPROVE® EXPERT, Ph. Eur., ChP, JP, NF

別名:

POE (20) ソルビタンモノオレエート, ポリエチレングリコールソルビタンモノオレアート, ポリオキシエチレンソルビタンモノオレアート, ポリソルベート80

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

CAS番号:
UNSPSC Code:
12352207
EC Index Number:
500-019-9
MDL number:
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


biological source

synthetic

Quality Level

grade

GMP, Halal, Kosher

agency

ChP, JP, NF, Ph. Eur.

description

GMO free, low in endotoxins

product line

EMPROVE® EXPERT

form

liquid

potency

42200 mg/kg LD50, oral

mol wt

1310 g/mol

impurities

endotoxins, low

pH

5-7 (20 °C, 50 g/L)

bp

>100 °C

density

1.07 g/cm3 at 25 °C

application(s)

liquid formulation
parenterals
pharmaceutical
solubility enhancement

foreign activity

Aflatoxin free

storage temp.

15-25°C

SMILES string

CCCCCCCC/C=C/CCCCCCCC(=O)OCCOCC(C1C(CC(O1)OCCO)OCCO)OCCO

InChI

1S/C32H60O10/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-30(36)40-25-24-37-27-29(39-22-19-34)32-28(38-21-18-33)26-31(42-32)41-23-20-35/h9-10,28-29,31-35H,2-8,11-27H2,1H3/b10-9+

InChI key

RGPBUVUVZKQNHD-MDZDMXLPSA-N

General description

Finding the right excipient that matches your needs as well as regulatory demands can be a complicated challenge in formulation. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Application

Polysorbate 80 is used to stabilize biomolecule formulations and as solubilizer, emulsifier and wetting agent in small molecule formulations. Polysorbates are known to degrade via autoxidation and hydrolysis. Degradation products can have a negative impact on the stability of the protein as well as the small molecule API. To reduce this risk, the polysorbate high-purity grade contains a low amount of impurities, especially peroxide.

Intended for high-risk applications, this Emprove® Expert grade contains bioburden and endotoxin limits.

Packaging

1371710100 / 100ml / glass bottle
1371711000 / 1L / glass bottle

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany
TWEEN is a registered trademark of Croda International PLC


Still not finding the right product?

Explore all of our products under TWEEN® 80


保管分類

10 - Combustible liquids

wgk

WGK 1

flash_point_c

> 113 °C - closed cup

flash_point_f

>235.4 °F - closed cup



Emprove®プログラムを使用してGMPを遵守します。

Emprove® Dossiersで資格認定を加速し、コンプライアンスを維持し、時間を節約しましょう。

Dossiers をダウンロード

注意: EmproveSuite.comに移動します。ユーザー名とパスワードはSigmaAldrich.comとは別のもので、異なる場合があります

無料会員登録すると、数分でEmprove® Dossiersにアクセスできます。 購読プランをアップグレードして、Emprove® Suiteの高度でカスタマイズされたコンテンツをアンロックしてください。

お探しのものが見つかりませんか?Emprove® プログラムのヘルプページをご覧ください。.

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする


資料

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

This article outlines critical factors in long-term stability of proteins, and how different stabilizers protect again mechanical and thermal stress.

関連コンテンツ

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

Learn more on mAb subcutaneous or intravenous formulation, and the relevant associated products, including excipients.